Ligand Pharmaceuticals is a biopharmaceutical company that develops or acquires technologies used in the discovery and development of medicines worldwide. Its commercial programs offer treatments for multiple myeloma, COVID-19, osteoporosis, and various other conditions. The company also partners with other companies and has licenses to develop treatments for numerous diseases such as cancer, diabetes, and cardiovascular disease.